Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY5R | Q15761 | 3/20 | 0.42 |
| ▸ | NPY1R | P25929 | 2/20 | 0.42 |
| ▸ | NPY4R | P50391 | 2/20 | 0.42 |
| ▸ | OPRL1 | P41146 | 5/20 | 0.41 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.40 |
| ▸ | QRFPR | Q96P65 | 1/20 | 0.40 |
| ▸ | FURIN | P09958 | 4/20 | 0.39 |
| ▸ | NMT2 | O60551 | 1/20 | 0.39 |
| ▸ | NMT1 | P30419 | 1/20 | 0.39 |
| ▸ | TFPI | P10646 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29533919 | 0.94 | NPY5R (0.42) | NPY5RNPY1RNPY4ROPRL1NPBWR1 | |
| SCHEMBL29533810 | 0.90 | NPY4R (0.44) | NPY5RNPY1RNPY4RNPBWR1QRFPR | |
| SCHEMBL29354924 | 0.88 | SLC15A2 (0.44) | NPY5RNPY1RNPY4RFURINNMT2 | |
| SCHEMBL30062951 | 0.88 | SLC15A2 (0.44) | NPY5RNPY1RNPY4RQRFPRNMT2 | |
| SCHEMBL29355811 | 0.88 | NPY4R (0.41) | NPY5RNPY1RNPY4RQRFPR | |
| SCHEMBL29357200 | 0.87 | NPBWR1 (0.44) | NPY5RNPY1RNPY4ROPRL1NPBWR1 | |
| SCHEMBL7861255 | 0.87 | NPY4R (0.47) | NPY5RNPY1RNPY4RFURINNMT2 | |
| SCHEMBL7861254 | 0.87 | NPY4R (0.47) | NPY5RNPY1RNPY4RFURINNMT2 | |
| SCHEMBL30997472 | 0.87 | QRFPR (0.41) | NPY5RNPY1RNPY4ROPRL1NPBWR1 | |
| SCHEMBL29435094 | 0.87 | SLC15A2 (0.45) | NPY5RNPY1RNPY4RQRFPRNMT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4642492-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| WO-2024240173-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2024-11-28 | — | — | WO | claimed |